Breaking News

Sartorius Supports ABL Europe Capacity Expansion

Successfully completes Viral Vector GMP manufacturing installation at Strasbourg facility

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sartorius Stedim Biotech S.A. (SSB), has been selected by ABL Europe as its primary supplier of single-use systems. Through a supply partnership with SSB, ABL Europe has increased and brought online new viral vector manufacturing capacity at its European facility in Strasbourg. ABL Europe provides viral vector GMP manufacturing services for oncolytic, vaccine and gene therapy projects in all stages of clinical development through to commercial launch. Sartorius has delivered a comprehensive G...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters